+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Extracorporeal Membrane Oxygenation Machine: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 280 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994176
UP TO OFF until Oct 24th 2024
The extracorporeal membrane oxygenation machine (ECMO) market was valued at $504.2 million in 2023, and is projected to reach $793.7 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033.

Extracorporeal membrane oxygenation machine (ECMO) is a medical device that assists in removal of carbon dioxide and sends oxygen-rich blood back to the body. The machine serves as a life support system to treat individuals suffering from cardiac and pulmonary dysfunction. ECMO functions by circulating blood through an artificial lung (membrane oxygenator) and back into the bloodstream. This process allows the blood to be oxygenated and carbon dioxide to be removed, effectively mimicking the functions of human lungs and heart.

The growth of the global extracorporeal membrane oxygenation machine (ECMO) market is majorly driven by alarming rise in prevalence of respiratory and cardiac diseases such as heart failure and cardiogenic shock. According to the estimates of the Office of National Statistics, UK, approximately 6.6 million individuals were suffering from either a cardiovascular or respiratory condition. Among these, 3.5 million individuals were reported to have a cardiovascular condition, whereas 3.7 million had a respiratory condition. Moreover, increase in awareness among healthcare providers and advancements in medical training lead have led to a wider adoption of ECMO. Based on the June 2023 assessment by the Extracorporeal Life Support Organization (ELSO) registry, ECMO was used on 151,683 patients in 2020. Among these, 75,735 were adults, 30,743 were children, and 45,205 were neonates. Furthermore, surge in geriatric population notably contributes toward the market growth. . This is attributed to the fact that aged individuals are highly susceptible to chronic diseases and organ failure due to functional impairment that limit the ability to carry out day-to-day chores, thus boosting the demand for ECMO. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050, which is likely to significantly contribute toward the market growth. However, initial investment and maintenance costs of ECMO systems and dearth of skilled personnel to operate the system hamper the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, continuous improvements in ECMO technology, including more compact and efficient systems, and increase in government funding and support to set up & develop critical care infrastructure are expected to offer lucrative opportunities for the expansion of the market during the forecast period.

The extracorporeal membrane oxygenation machine (ECMO) market is segmented into type, component, application, and region. Depending on type, the market is classified into veno-arterial, veno-venous, and arterio-venous. As per component, it is classified into pumps, oxygenator, controllers, and others. On the basis of application, it is segregated into adult, pediatric, and neonates. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the arterio-venous machine segment is expected to dominate the market by 2033.

On the basis of component, oxygenator is anticipated to emerge as a leading segment during the forecast period.

Depending on application, the adult segment is projected to exhibit notable CAGR in the coming years.

Region wise, North America was the major revenue contributor in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global extracorporeal membrane oxygenation machine (ECMO) market include Medtronic Plc, Sorin Group, Terumo Corporation, MAQUET Holding, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, GETINGE AB, Livanova Plc., and Fresnius Medical Care. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to gain a strong foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Type

  • Veno-arterial
  • Veno-venous
  • Others

By Components

  • Pumps
  • Oxygenator
  • Controllers
  • Others

By Application

  • Adult
  • Pediatric
  • Neonates

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • Medtronic Plc
  • Sorin Group
  • Terumo Corporation
  • MAQUET Holding
  • Nipro Medical Corporation
  • Microport Scientific Corporation
  • Medos Medizintechnik AG
  • GETINGE AB
  • Livanova Plc
  • Fresnius Medical Care

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Veno-arterial
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Veno-venous
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Others
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS
5.1. Market Overview
5.1.1 Market Size and Forecast, By Components
5.2. Pumps
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Oxygenator
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Controllers
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Others
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
CHAPTER 6: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Adult
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Pediatric
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Neonates
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Type
7.2.3. Market Size and Forecast, By Components
7.2.4. Market Size and Forecast, By Application
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.2.6.1. Market Size and Forecast, By Type
7.2.6.2. Market Size and Forecast, By Components
7.2.6.3. Market Size and Forecast, By Application
7.2.7. Canada Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.2.7.1. Market Size and Forecast, By Type
7.2.7.2. Market Size and Forecast, By Components
7.2.7.3. Market Size and Forecast, By Application
7.2.8. Mexico Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.2.8.1. Market Size and Forecast, By Type
7.2.8.2. Market Size and Forecast, By Components
7.2.8.3. Market Size and Forecast, By Application
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Type
7.3.3. Market Size and Forecast, By Components
7.3.4. Market Size and Forecast, By Application
7.3.5. Market Size and Forecast, By Country
7.3.6. France Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.3.6.1. Market Size and Forecast, By Type
7.3.6.2. Market Size and Forecast, By Components
7.3.6.3. Market Size and Forecast, By Application
7.3.7. Germany Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.3.7.1. Market Size and Forecast, By Type
7.3.7.2. Market Size and Forecast, By Components
7.3.7.3. Market Size and Forecast, By Application
7.3.8. Italy Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.3.8.1. Market Size and Forecast, By Type
7.3.8.2. Market Size and Forecast, By Components
7.3.8.3. Market Size and Forecast, By Application
7.3.9. Spain Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.3.9.1. Market Size and Forecast, By Type
7.3.9.2. Market Size and Forecast, By Components
7.3.9.3. Market Size and Forecast, By Application
7.3.10. UK Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.3.10.1. Market Size and Forecast, By Type
7.3.10.2. Market Size and Forecast, By Components
7.3.10.3. Market Size and Forecast, By Application
7.3.11. Rest Of Europe Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.3.11.1. Market Size and Forecast, By Type
7.3.11.2. Market Size and Forecast, By Components
7.3.11.3. Market Size and Forecast, By Application
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Type
7.4.3. Market Size and Forecast, By Components
7.4.4. Market Size and Forecast, By Application
7.4.5. Market Size and Forecast, By Country
7.4.6. China Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.4.6.1. Market Size and Forecast, By Type
7.4.6.2. Market Size and Forecast, By Components
7.4.6.3. Market Size and Forecast, By Application
7.4.7. Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.4.7.1. Market Size and Forecast, By Type
7.4.7.2. Market Size and Forecast, By Components
7.4.7.3. Market Size and Forecast, By Application
7.4.8. India Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.4.8.1. Market Size and Forecast, By Type
7.4.8.2. Market Size and Forecast, By Components
7.4.8.3. Market Size and Forecast, By Application
7.4.9. South Korea Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.4.9.1. Market Size and Forecast, By Type
7.4.9.2. Market Size and Forecast, By Components
7.4.9.3. Market Size and Forecast, By Application
7.4.10. Australia Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.4.10.1. Market Size and Forecast, By Type
7.4.10.2. Market Size and Forecast, By Components
7.4.10.3. Market Size and Forecast, By Application
7.4.11. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.4.11.1. Market Size and Forecast, By Type
7.4.11.2. Market Size and Forecast, By Components
7.4.11.3. Market Size and Forecast, By Application
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Type
7.5.3. Market Size and Forecast, By Components
7.5.4. Market Size and Forecast, By Application
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.5.6.1. Market Size and Forecast, By Type
7.5.6.2. Market Size and Forecast, By Components
7.5.6.3. Market Size and Forecast, By Application
7.5.7. South Africa Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.5.7.1. Market Size and Forecast, By Type
7.5.7.2. Market Size and Forecast, By Components
7.5.7.3. Market Size and Forecast, By Application
7.5.8. Saudi Arabia Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.5.8.1. Market Size and Forecast, By Type
7.5.8.2. Market Size and Forecast, By Components
7.5.8.3. Market Size and Forecast, By Application
7.5.9. Rest of LAMEA Extracorporeal Membrane Oxygenation Machine (ECMO) Market
7.5.9.1. Market Size and Forecast, By Type
7.5.9.2. Market Size and Forecast, By Components
7.5.9.3. Market Size and Forecast, By Application
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Medtronic Plc
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Sorin Group
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Terumo Corporation
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. MAQUET Holding
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Nipro Medical Corporation
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Microport Scientific Corporation
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Medos Medizintechnik AG
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. GETINGE AB
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Livanova Plc
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Fresnius Medical Care
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 2. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR VENO-ARTERIAL, BY REGION, 2024 - 2033 ($MILLION)
TABLE 3. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR VENO-VENOUS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 4. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 6. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR PUMPS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 7. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR OXYGENATOR, BY REGION, 2024 - 2033 ($MILLION)
TABLE 8. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR CONTROLLERS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 9. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 11. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR ADULT, BY REGION, 2024 - 2033 ($MILLION)
TABLE 12. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR PEDIATRIC, BY REGION, 2024 - 2033 ($MILLION)
TABLE 13. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR NEONATES, BY REGION, 2024 - 2033 ($MILLION)
TABLE 14. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY REGION, 2024 - 2033 ($MILLION)
TABLE 15. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 16. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 17. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 18. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 19. U.S. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 20. U.S. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 21. U.S. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 22. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 23. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 24. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 25. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 26. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 27. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 28. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 29. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 30. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 31. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 32. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 33. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 34. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 35. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 36. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 37. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 38. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 39. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 40. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 41. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 42. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 43. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 44. UK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 45. UK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 46. UK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 47. REST OF EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 48. REST OF EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 49. REST OF EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 50. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 51. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 52. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 53. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 54. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 55. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 56. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 57. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 58. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 59. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 60. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 61. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 62. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 63. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 64. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 65. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 66. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 67. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 68. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 72. LAMEA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 73. LAMEA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 74. LAMEA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 75. LAMEA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 76. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 77. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 78. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 79. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 80. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 81. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 82. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 83. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 84. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 85. REST OF LAMEA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 86. REST OF LAMEA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS, 2024 - 2033 ($MILLION)
TABLE 87. REST OF LAMEA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 88. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 89. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 90. MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 91. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 92. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 93. SORIN GROUP: KEY EXECUTIVES
TABLE 94. SORIN GROUP: COMPANY SNAPSHOT
TABLE 95. SORIN GROUP: OPERATING SEGMENTS
TABLE 96. SORIN GROUP: PRODUCT PORTFOLIO
TABLE 97. SORIN GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 98. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 99. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 100. TERUMO CORPORATION: OPERATING SEGMENTS
TABLE 101. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 102. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103. MAQUET HOLDING: KEY EXECUTIVES
TABLE 104. MAQUET HOLDING: COMPANY SNAPSHOT
TABLE 105. MAQUET HOLDING: OPERATING SEGMENTS
TABLE 106. MAQUET HOLDING: PRODUCT PORTFOLIO
TABLE 107. MAQUET HOLDING: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108. NIPRO MEDICAL CORPORATION: KEY EXECUTIVES
TABLE 109. NIPRO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 110. NIPRO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 111. NIPRO MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 112. NIPRO MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113. MICROPORT SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 114. MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 115. MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 116. MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 117. MICROPORT SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 118. MEDOS MEDIZINTECHNIK AG: KEY EXECUTIVES
TABLE 119. MEDOS MEDIZINTECHNIK AG: COMPANY SNAPSHOT
TABLE 120. MEDOS MEDIZINTECHNIK AG: OPERATING SEGMENTS
TABLE 121. MEDOS MEDIZINTECHNIK AG: PRODUCT PORTFOLIO
TABLE 122. MEDOS MEDIZINTECHNIK AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 123. GETINGE AB: KEY EXECUTIVES
TABLE 124. GETINGE AB: COMPANY SNAPSHOT
TABLE 125. GETINGE AB: OPERATING SEGMENTS
TABLE 126. GETINGE AB: PRODUCT PORTFOLIO
TABLE 127. GETINGE AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 128. LIVANOVA PLC: KEY EXECUTIVES
TABLE 129. LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 130. LIVANOVA PLC: OPERATING SEGMENTS
TABLE 131. LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 132. LIVANOVA PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 133. FRESNIUS MEDICAL CARE: KEY EXECUTIVES
TABLE 134. FRESNIUS MEDICAL CARE: COMPANY SNAPSHOT
TABLE 135. FRESNIUS MEDICAL CARE: OPERATING SEGMENTS
TABLE 136. FRESNIUS MEDICAL CARE: PRODUCT PORTFOLIO
TABLE 137. FRESNIUS MEDICAL CARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALEXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET
FIGURE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET SEGMENTATION, BY TYPE
FIGURE 11. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR VENO-ARTERIAL, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 12. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR VENO-VENOUS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 13. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET SEGMENTATION, BY COMPONENTS
FIGURE 15. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR PUMPS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 16. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR OXYGENATOR, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 17. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR CONTROLLERS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 18. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 19. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET SEGMENTATION, BY APPLICATION
FIGURE 20. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR ADULT, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 21. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR PEDIATRIC, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 22. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET FOR NEONATES, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 27. COMPETITIVE DASHBOARD
FIGURE 28. COMPETITIVE HEATMAP: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET
FIGURE 29. TOP PLAYER POSITIONING, 2023
FIGURE 30. MEDTRONIC PLC: NET SALES, 2021-2023 ($MILLION)
FIGURE 31. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. SORIN GROUP: NET SALES, 2021-2023 ($MILLION)
FIGURE 34. SORIN GROUP: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. SORIN GROUP: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. TERUMO CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 37. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. MAQUET HOLDING: NET SALES, 2021-2023 ($MILLION)
FIGURE 40. MAQUET HOLDING: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. MAQUET HOLDING: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. NIPRO MEDICAL CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 43. NIPRO MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. NIPRO MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. MICROPORT SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 46. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. MEDOS MEDIZINTECHNIK AG: NET SALES, 2021-2023 ($MILLION)
FIGURE 49. MEDOS MEDIZINTECHNIK AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. MEDOS MEDIZINTECHNIK AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. GETINGE AB: NET SALES, 2021-2023 ($MILLION)
FIGURE 52. GETINGE AB: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. GETINGE AB: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 54. LIVANOVA PLC: NET SALES, 2021-2023 ($MILLION)
FIGURE 55. LIVANOVA PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 56. LIVANOVA PLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 57. FRESNIUS MEDICAL CARE: NET SALES, 2021-2023 ($MILLION)
FIGURE 58. FRESNIUS MEDICAL CARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 59. FRESNIUS MEDICAL CARE: REVENUE SHARE, BY REGION, 2023 (%)

Companies Mentioned

  • Medtronic Plc
  • Sorin Group
  • Terumo Corporation
  • MAQUET Holding
  • Nipro Medical Corporation
  • Microport Scientific Corporation
  • Medos Medizintechnik AG
  • GETINGE AB
  • Livanova Plc
  • Fresnius Medical Care

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information